Author:
Mishra Ayan,Panda Barsha,Ghosh Debosree
Abstract
Non Alcoholic Fatty Liver Disease (NAFDL) is a condition in which an individual suffers from an accumulation of fat in the liver. This is a disease condition with a multifactorial etiology. Some potent causes of such conditions are altered thyroid condition, abnormal metabolism in the body due to aging or menopause, or any other hormonal imbalance. Most of these causes are regulated by genetics, lifestyle, and environmental factors. Menopause comes with tremendous hormonal turmoil in the human body and brings various abnormal conditions that significantly divert from physiological conditions. One such condition that comes along with menopause in women is NAFLD. Also, the progression of NAFDL is more in post-menopausal women than in premenopausal women. This review aims to comprehend and understand from the existing literature if the prevailing NAFLD condition worsens and aggravates in women with menopause or remains unaffected. This short review briefly discusses the pathophysiology of the onset and progression of NAFDL in post-menopausal women. Lifestyle restrictions, diet, proper monitoring, and medications and supplementations are the only ways to manage NAFLD in post-menopausal women. A detailed and better understanding of NAFDL, its onset, progression, and association with the physiological condition of post-menopausal women is necessary to better manage and treat the NAFDL condition in post-menopausal women.
Reference42 articles.
1. Venetsanaki V, Polyzos SA. Menopause and non-alcoholic fatty liver disease: A review focusing on therapeutic perspectives. Curr Vasc Pharmacol. 2019; 17: 546-555.
2. Robeva R, Mladenović D, Vesković M, Hrnčić D, Bjekić Macut J, Stanojlović O, et al. The interplay between metabolic dysregulations and non-alcoholic fatty liver disease in women after menopause. Maturitas. 2021; 151: 22-30.
3. National Institute of Diabetes and Digestive and Kidney Diseases. Definition & Facts of NAFLD & NASH [Internet]. Bethesda, MD, US: National Institutes of Health; 2021. Available from: https://www.niddk.nih.gov/health-information/liver-disease/nafld-nash/definition-facts.
4. Singha PS, Ghosh S, Ghosh D. Levothyroxine and non-alcoholic fatty liver disease: A mini review. Mini Rev Med Chem. 2023. Doi: 10.2174/1389557523666230314113543.
5. Paschou SA, Polyzos SA, Anagnostis P, Goulis DG, Kanaka Gantenbein C, Lambrinoudaki I, et al. Nonalcoholic fatty liver disease in women with polycystic ovary syndrome. Endocrine. 2020; 67: 1-8.
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献